Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Cyclin-dependent kinase 5 acts as a promising biomarker in clear cell Renal Cell Carcinoma
Liangsong Zhu, Rong Ding, Jianping Zhang, et al.
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 12

Showing 12 citing articles:

Standardization and harmonization of distributed multi-center proteotype analysis supporting precision medicine studies
Yue Xuan, Nicholas W. Bateman, Sébastien Gallien, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 70
Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer
Stéphanie Papin, Paolo Paganetti
Brain Sciences (2020) Vol. 10, Iss. 11, pp. 862-862
Open Access | Times Cited: 34
A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights
Mohammad M. Al‐Sanea, Ahmad J. Obaidullah, Mohamed E. Shaker, et al.
Molecules (2021) Vol. 26, Iss. 2, pp. 412-412
Open Access | Times Cited: 24
HA-ADT suppresses esophageal squamous cell carcinoma progression via apoptosis promotion and autophagy inhibition
Shaofeng Duan, Mengmeng Zhang, Xin Zhang, et al.
Experimental Cell Research (2022) Vol. 420, Iss. 1, pp. 113341-113341
Closed Access | Times Cited: 10
The functions and properties of cullin-5, a potential therapeutic target for cancers.
Feng Gao, Yimin Fan, Bolun Zhou, et al.
PubMed (2020) Vol. 12, Iss. 2, pp. 618-632
Closed Access | Times Cited: 15
Favorable Immunotherapy Plus Tyrosine Kinase Inhibition Outcome of Renal Cell Carcinoma Patients with Low CDK5 Expression
Xianglai Xu, Ying Wang, Zhaoyi Chen, et al.
Cancer Research and Treatment (2023) Vol. 55, Iss. 4, pp. 1321-1336
Open Access | Times Cited: 5
CDK5 promotes apoptosis and attenuates chemoresistance in gastric cancer via E2F1 signaling
Long‐Long Cao, Yukai Wu, Tong-Xin Lin, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Novel VHL substrate targets SFMBT1 and ZHX2 may be important prognostic predictors in patients with ccRCC
Yufeng Chen, Liangsong Zhu, Song Xue, et al.
Oncology Letters (2021) Vol. 21, Iss. 5
Open Access | Times Cited: 8
Cystathionine β-Synthase Regulates the Proliferation, Migration, and Invasion of Thyroid Carcinoma Cells
Qiying Jiang, Jian‐Mei Li, Mi‐Rong Jing, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-27
Open Access | Times Cited: 5
Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma
Qianqian Zhang, Ying‐Ran Gao, Yanxia Zhang, et al.
Oncogene (2022) Vol. 41, Iss. 49, pp. 5238-5252
Closed Access | Times Cited: 5
Tau: At the Interface Between Neurodegeneration and Cancer?
Stéphanie Papin, Paolo Paganetti
(2020)
Open Access | Times Cited: 1
Cystathionine γ-lyase mediates cell proliferation, migration, and invasion of nasopharyngeal carcinoma
Qianqian Zhang, Ying‐Ran Gao, Yanxia Zhang, et al.
Research Square (Research Square) (2022)
Open Access
Page 1

Scroll to top